Cost Effectiveness and Resource Allocation

Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in Singapore

Fig. 2

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com